ClinicalTrials.gov

Key Record Dates

ClinicalTrials.gov Identifier: NCT02409342
Brief Title: A Study of Atezolizumab (MPDL3280A) Compared With a Platinum Agent (Cisplatin or Carboplatin) + (Pemetrexed or Gemcitabine) in Participants With Stage IV Non-Squamous or Squamous Non-Small Cell Lung Cancer (NSCLC) [IMpower110]

First Submitted : April 1, 2015
First Submitted that Met QC Criteria : April 1, 2015
First Posted : April 6, 2015 (Estimate)

Last Update Submitted that Met QC Criteria : January 7, 2019
Last Update Posted : January 9, 2019